These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10830785)

  • 21. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.
    Horikawa YT; Panneerselvam M; Kawaraguchi Y; Tsutsumi YM; Ali SS; Balijepalli RC; Murray F; Head BP; Niesman IR; Rieg T; Vallon V; Insel PA; Patel HH; Roth DM
    J Am Coll Cardiol; 2011 May; 57(22):2273-83. PubMed ID: 21616289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tumor necrosis factor-alpha-dependent cardiomyocyte apoptosis by metallothionein.
    Klein JB; Wang GW; Zhou Z; Buridi A; Kang YJ
    Cardiovasc Toxicol; 2002; 2(3):209-18. PubMed ID: 12665666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
    Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Kishimoto I; Rossi K; Garbers DL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congestive heart failure in copper-deficient mice.
    Elsherif L; Ortines RV; Saari JT; Kang YJ
    Exp Biol Med (Maywood); 2003 Jul; 228(7):811-7. PubMed ID: 12876300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice.
    Sangaralingham SJ; Tse MY; Pang SC
    J Endocrinol; 2007 Jul; 194(1):143-52. PubMed ID: 17592028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant metallothionein alleviates endoplasmic reticulum stress-induced myocardial apoptosis and contractile dysfunction.
    Yang L; Wang J; Yang J; Schamber R; Hu N; Nair S; Xiong L; Ren J
    Free Radic Res; 2015 Oct; 49(10):1187-98. PubMed ID: 25968954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
    Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
    J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury.
    Song Y; Wang J; Li Y; Du Y; Arteel GE; Saari JT; Kang YJ; Cai L
    Am J Pathol; 2005 Jul; 167(1):17-26. PubMed ID: 15972948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling.
    Hall EJ; Pal S; Glennon MS; Shridhar P; Satterfield SL; Weber B; Zhang Q; Salama G; Lal H; Becker JR
    Cardiovasc Res; 2022 Jul; 118(9):2124-2138. PubMed ID: 34329394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antioxidant function of metallothionein in the heart.
    Kang YJ
    Proc Soc Exp Biol Med; 1999 Dec; 222(3):263-73. PubMed ID: 10601885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivo.
    Miao X; Tang Z; Wang Y; Su G; Sun W; Wei W; Li W; Miao L; Cai L; Tan Y; Liu Q
    Toxicol Lett; 2013 Jul; 220(3):277-85. PubMed ID: 23664956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.
    Xu J; Wang G; Wang Y; Liu Q; Xu W; Tan Y; Cai L
    J Cell Mol Med; 2009 Aug; 13(8A):1499-512. PubMed ID: 19583814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
    Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
    J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity.
    Sun X; Kang YJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):652-7. PubMed ID: 12192109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.
    Wang D; Gladysheva IP; Fan TH; Sullivan R; Houng AK; Reed GL
    Hypertension; 2014 Mar; 63(3):514-9. PubMed ID: 24379183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
    Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor.
    Wang X; McLennan SV; Allen TJ; Tsoutsman T; Semsarian C; Twigg SM
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1490-500. PubMed ID: 19625611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.